Genmab A/S announced that Martine van Vugt has been appointed to Chief Strategy Officer and promoted to Executive Vice President effective March 29, 2023. Martine will oversee Corporate Strategy, Corporate Development, Business Development and Licensing and Alliance Management. Martine joined Genmab in 2001 and most recently served as Genmab's Senior Vice President, Corporate Strategy & Planning.

She will continue her role as a member of the Executive Committee with Genmab's President and Chief Executive Officer Dr. Jan van de Winkel, Chief Development Officer Dr. Judith Klimovsky, Chief Financial Officer Anthony Pagano, Chief Medical Officer Dr. Tahi Ahmadi, Chief Operating Officer Anthony Mancini, Chief Legal Officer Birgitte Stephensen, and Chief People Officer Chris Cozic. Based in Genmab's Global R&D Center in Utrecht, the Netherlands, Martine began her career in scientific and research positions and gained increased responsibility through her time at Genmab leading to extensive experience as participant in many of Genmab's governance fora. She is a critical contributor to multiple business development strategic collaborations and has been instrumental in the structure and negotiations of key partnerships, among them Genmab's collaborations with Janssen, BioNTech, and AbbVie.

Martine has a Ph.D. in Immunology from Utrecht University and a Master of Science degree in Biology from Wageningen University.